Leadership

Dr. Doug Flora is an oncologist and executive clinical leader with over 20 years of experience, dedicated to ending cancer as we know it.

A graduate of The Ohio State University College of Medicine and Public Health, he is also a Lean Six Sigma Black Belt certified professional. At St. Elizabeth Healthcare, he serves as the Executive Medical Director of Oncology Services, where he directs clinical operations, strategic planning, and the expansion of their cancer programs.

He co-founded the Center for Precision Medicine & Genomic Health, leading innovative precision medicine programs and research, and established a national model cancer screening program. Dr. Flora's efforts include planning, constructing, and fundraising for two state-of-the-art cancer centers, supporting over sixty oncology providers across six centers.

As Editor-in-Chief of AI in Precision Oncology, the first peer-reviewed academic journal on the subject, he works to advance knowledge and integration of AI in oncology.

Dr. Sanjay Juneja is a triple board certified hematologist & medical oncologist, international keynote speaker and the largest followed oncologist globally for his social & news media education as @TheOncDoc.

He is the host of his own "Target Cancer: Podcast", spanning over two million downloads in over 120 countries and an Editorial Board Member of the peer-reviewed journal A.I. in Precision Oncology.

Dr. Juneja's accolades include being named Targeted Oncology's inaugural 2024 Oncology Icon, an invitation to the White House's 2023 Healthcare Leaders in Social Media Roundtable, and recognition as a 40 Under 40 honoree. His insights have been featured in The Washington Post, WIRED Magazine, Bloomberg, and PBS.

In addition to co-founding TensorBlack, Dr. Juneja serves as Vice President of Clinical AI Operations at Tempus AI and is a contributing writer and serves on the Technology Council for Forbes.

Dr. Debra Patt is a practicing oncologist and breast cancer specialist in Austin, Texas.

She is an active leader in breast cancer research and healthcare informatics, driving digital healthcare tool adoption in clinical practice to improve the patient journey. She is the managing partner for the central Texas, Gulf, and Rio Grande Valley regions in Texas Oncology since 2023.

Dr. Patt is the medical director for public policy for The US Oncology Network and has testified before the US Congress and Senate to protect access to care for cancer patients. She has chaired the council on legislation and the cancer committee for the Texas Medical Association.

Dr. Patt serves as the current vice president of the Community Oncology Alliance and on the ASCO Board of Directors. She also chairs the Artificial Intelligence Task Force for ASCO and is the liaison for the clinical innovation committee. She lectures medical students and is a professor at Dell Medical School at The University of Texas at Austin.

Dr. Olalekan Ajayi, a transformative leader in healthcare, seamlessly blends his clinical expertise as a Doctor of Pharmacy with the strategic acumen of an MBA to champion the innovation of the oncology workforce.

Currently serving as the Chief Operating Officer at Highlands Oncology Group in Northwest Arkansas, Dr. Ajayi orchestrates the complex operations of this multi-specialty cancer center network and fosters a culture of continuous learning and development.

Dr. Ajayi's passion for operational excellence is evident in his impressive track record. His ability to coach and inspire senior leaders, build high-performance teams, and instill a culture of continuous improvement is remarkable. Earlier in his career, he demonstrated his entrepreneurial spirit by building an oncology pharmacy program and serving as an Adjunct Faculty member at the University of Wyoming School of Pharmacy.

As President of the Association of Cancer Care Centers (2023-2024), his theme focused on providing oncology professionals with the tools and resources they need to stay at the forefront of this rapidly evolving field.

Dr. David R. Penberthy has over three decades of clinical experience as a physician, and has been in the clinical practice of oncology since 1998 as a private practitioner and academic physician.

Dr. Penberthy understands the wider societal issues facing oncology patients and professionals in part through his position as President of the Association of Cancer Care Centers, a leading national education and advocacy organization, the membership of which cares for approximately two-thirds of the oncology care delivered in the USA.

After earning his Bachelor of Science degree in Electrical Engineering from Virginia Tech and a Doctor of Medicine degree from Virginia Commonwealth University, Dr. Penberthy completed a surgical internship at Bethesda Naval Hospital and subsequently served as a U.S. Navy Flight Surgeon with Fighter Squadron 101.

His strong interest in technology led him to the field of Radiation Oncology. He earned an MBA degree from the Darden Graduate School of Business at the University of Virginia in 2011. Dr. Penberthy is entrepreneurial, and is interested in applying next-generation technology solutions to improve the health of humanity.